Paper33535458
The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment.
Silk N and 5 others. J Xenobiot, 2021. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment. Papers, record 33535458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33535458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11160159 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11160159 | PubMed |
| 2 | 27279239 | Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment. | Crit Rev Oncog | 2015 | https://conductscience.org/library/papers/27279239 | PubMed |
| 3 | 31550284 | Expression of Concern: Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor. | PLoS One | 2019 | https://conductscience.org/library/papers/31550284 | PubMed |
| 4 | 9751731 | Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9751731 | PubMed |
| 5 | 21965742 | Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells. | Anticancer Res | 2011 | https://conductscience.org/library/papers/21965742 | PubMed |
| 6 | 22651903 | Interleukin-6 signaling pathway in targeted therapy for cancer. | Cancer Treat Rev | 2012 | https://conductscience.org/library/papers/22651903 | PubMed |
| 7 | 7879350 | Interleukin-6: a candidate mediator of human prostate cancer morbidity. | Urology | 1995 | https://conductscience.org/library/papers/7879350 | PubMed |
| 8 | 28945937 | Resveratrol and inflammatory bowel disease. | Ann N Y Acad Sci | 2017 | https://conductscience.org/library/papers/28945937 | PubMed |
| 9 | 22288443 | Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrol. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22288443 | PubMed |
| 10 | 15807660 | Mitochondrial metabolism of reactive oxygen species. | Biochemistry (Mosc) | 2005 | https://conductscience.org/library/papers/15807660 | PubMed |
| 11 | 27458528 | Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? | Cancer Biol Med | 2016 | https://conductscience.org/library/papers/27458528 | PubMed |
| 12 | 12492490 | Role of stroma in carcinogenesis of the prostate. | Differentiation | 2002 | https://conductscience.org/library/papers/12492490 | PubMed |
| 13 | 25414773 | Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells. | Biomol Ther (Seoul) | 2014 | https://conductscience.org/library/papers/25414773 | PubMed |
| 14 | 16520032 | Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. | Eur J Cancer | 2006 | https://conductscience.org/library/papers/16520032 | PubMed |
| 15 | 29330583 | Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice. | World J Urol | 2018 | https://conductscience.org/library/papers/29330583 | PubMed |
| 16 | 30131604 | Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. | Prostate Cancer Prostatic Dis | 2019 | https://conductscience.org/library/papers/30131604 | PubMed |
| 17 | 16465179 | Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16465179 | PubMed |
| 18 | 15467730 | CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. | Lab Invest | 2004 | https://conductscience.org/library/papers/15467730 | PubMed |
| 19 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 24744523 | BPH and prostate cancer risk. | Indian J Urol | 2014 | https://conductscience.org/library/papers/24744523 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42414255 | Aging and cancer: current understandings and future perspectives. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42414255 | PubMed |
| 41794917 | Key hub genes identification and therapeutic target prediction via multi-validation for the senescence-inflammation axis in prostate cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41794917 | PubMed |
| 41602838 | Research advances on the risk of prostate cancer from phthalates exposure: from epidemiological evidence to multidimensional prevention and control. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41602838 | PubMed |
| 40143065 | Therapeutic Potential of Plant- and Marine-Derived Bioactive Compounds in Prostate Cancer: Mechanistic Insights and Translational Applications. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143065 | PubMed |
| 39512496 | Potential antitumor effect of polysaccharides extracted from Polygonatum sibiricum on human prostate cancer PC‑3 cells. | Oncol Lett | 2025 | https://conductscience.org/library/papers/39512496 | PubMed |
| 38994760 | Cellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge (Review). | Mol Med Rep | 2024 | https://conductscience.org/library/papers/38994760 | PubMed |
| 38596366 | Phytochemical identification and in silico elucidation of interactions of bioactive compounds from Citrullus lanatus with androgen receptor towards prostate cancer treatment. | In Silico Pharmacol | 2024 | https://conductscience.org/library/papers/38596366 | PubMed |
| 37299500 | Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer. | Nutrients | 2023 | https://conductscience.org/library/papers/37299500 | PubMed |
| 36829966 | Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36829966 | PubMed |
| 35928802 | HS-1793 inhibits cell proliferation in lung cancer by interfering with the interaction between p53 and MDM2. | Oncol Lett | 2022 | https://conductscience.org/library/papers/35928802 | PubMed |
| 35680563 | Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression. | Aging (Albany NY) | 2022 | https://conductscience.org/library/papers/35680563 | PubMed |
| 34967561 | Role of Resveratrol as Radiosensitizer by Targeting Cancer Stem Cells in Radioresistant Prostate Cancer Cells (PC-3). | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/34967561 | PubMed |
| 34273003 | Resveratrol effects in oral cancer cells: a comprehensive review. | Med Oncol | 2021 | https://conductscience.org/library/papers/34273003 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33535458
GET https://conductscience.org/api/papers/v1/33535458/references?page=2